Latest News

With a price-to-earnings (or "P/E") ratio of 16.4x Meiko Electronics Co., Ltd. ( TSE:6787 ) may be sending bearish...

Australian shares are poised for further gains this week, buoyed by a surge in copper prices, with the ASX futures indicating an upward trend. While penny stocks might seem like a throwback to earlier trading days, they remain relevant for investors seeking opportunities beyond the well-known giants. These smaller or newer companies can offer surprising value when backed by solid financial foundations, and we've identified three such stocks on the ASX that combine balance sheet strength with...

Key Insights The projected fair value for Komatsu is JP¥8,357 based on 2 Stage Free Cash Flow to Equity Current share...

Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...

Key Insights The considerable ownership by private equity firms in Sembcorp Industries indicates that they collectively...

JP Morgan’s downgrade of Cognex (CGNX) to a more cautious rating has put the stock back under the microscope, as investors reassess how its automation story lines up with near term growth expectations. See our latest analysis for Cognex. The downgrade lands after a choppy stretch, with a 30 day share price return of minus 9.62 percent and a 5 year total shareholder return of minus 47.58 percent, signaling that momentum has been fading despite recent operational progress. If this shift in...

GE Vernova (GEV) and Taiwan Power Company just struck a deal for 25 onshore wind repower upgrade kits, plus five years of services, signaling a clear push to scale GE Vernova's renewables footprint in Asia. See our latest analysis for GE Vernova. The deal lands while GE Vernova's share price has climbed to $601.97, with a strong year to date share price return hinting that investors see building momentum behind its renewables and broader energy transition story rather than fading...

Sumitomo Electric Industries (TSE:5802) just renewed its framework purchase agreement with SEI Optical, locking in optical fibre preform and equipment supply through 2026, and the stock immediately outpaced a falling Nikkei with a roughly 3% gain. See our latest analysis for Sumitomo Electric Industries. The renewed framework deal seems to have landed on an already strong uptrend, with a 1 month share price return of 21.04% feeding into a 142.78% year to date share price gain and a 5 year...

EssilorLuxottica Société anonyme (ENXTPA:EL) just set up a high profile Scientific Advisory Committee, and while that will not move earnings overnight, it quietly sharpens the long term innovation story behind the stock. See our latest analysis for EssilorLuxottica Société anonyme. That scientific committee announcement lands after a strong run, with the share price up sharply over the past year and especially the last quarter, while multi year total shareholder returns highlight enduring...

If you are wondering whether Hudbay Minerals is still a smart buy after its huge run up, you are not alone. This is exactly where valuation starts to matter most. The stock is up 4.3% over the last week, 9.0% over the past month, and an eye catching 98.0% year to date, building on a 94.1% 1 year gain and a massive 234.8% return over 3 years. Much of this momentum has been driven by stronger copper sentiment and renewed interest in miners leveraged to long term electrification themes, with...

Wondering if Kellanova is still fairly priced after its long run, or if there is more upside left in the tank? This breakdown will help you decide whether the current share price actually makes sense. The stock has been mostly treading water in the short term, down 0.6% over the last week and roughly flat over the past month at 0.1%. However, that hides a steadier climb of 2.6% year to date and 6.2% over the last year, compounding into 32.5% and 69.5% gains over the past 3 and 5...

First Mining Gold (TSX:FF) is back on investors radar as it advances engineering and community work at its flagship Springpole project, following an updated study that sharpened the project plan and regional alignment. See our latest analysis for First Mining Gold. Those Springpole updates seem to be landing with investors, with the stock’s recent 90 day share price return of 128.57 percent and year to date share price return of 300 percent backing a 269.23 percent one year total shareholder...

GE HealthCare Technologies (GEHC) just used RSNA 2025 to roll out a packed slate of AI imaging launches and new hospital alliances, signaling a deliberate push to own more of the precision medicine workflow. See our latest analysis for GE HealthCare Technologies. The flurry of RSNA product unveilings and new alliances with Mayo Clinic and URMC appears to be resonating, with a roughly 12 percent 1 month share price return and firmer sentiment after tariff driven weakness earlier this year,...

TJX Companies (TJX) just posted another solid quarter, with Q3 2026 revenue of about $15.1 billion, Basic EPS of $1.28, and net income of $1.4 billion setting the tone for its latest update. The company has seen revenue move from roughly $14.1 billion and EPS of $1.15 in Q3 2025 to $15.1 billion and $1.28 this quarter, while trailing twelve month revenue has climbed to about $59.0 billion alongside EPS of $4.58 and net income of $5.1 billion, giving investors a clear view of steady top and...

Furukawa Electric Co., Ltd. previously announced that it had sold part of its investment securities, booking an extraordinary income gain of ¥16,000,000,000 that is already reflected in its earnings forecast for the fiscal year ending March 31, 2026. The move highlights management’s focus on improving asset efficiency and strengthening the balance sheet by reallocating capital away from non-core investment holdings. Next, we’ll examine how this large one-off gain from selling investment...

Cantor Fitzgerald recently reaffirmed its Overweight rating on Intuitive Machines, highlighting the completed Lanteris acquisition and several upcoming NASA-related contract decisions and missions as key near-term catalysts. This cluster of potential Lunar Terrain Vehicle and CLPS CT4 contract awards, alongside the planned IM-3 lunar mission, has sharpened investor focus on how quickly Intuitive Machines can convert technical capabilities into recurring revenue. Next, we’ll explore how the...

Sigma Lithium (SGML) is back in the spotlight after its high profile push at COP30, where management showcased a Quintuple Zero ESG model that directly ties Brazil’s lithium ambitions to cleaner, lower impact production. See our latest analysis for Sigma Lithium. The COP30 spotlight has coincided with a sharp 30 day share price return of 87.02% from Sigma Lithium. Yet its year to date share price return remains negative, and the three year total shareholder return of 71.59% is still deeply...

RLI (RLI) has quietly slipped this year, with the stock down about 23% year to date even as its long term track record and underwriting discipline remain intact. This creates an interesting setup for patient investors. See our latest analysis for RLI. The 6.8% 1 month share price return suggests some buyers are stepping back in after a weak start to the year, even though the year to date share price return is still firmly negative and the 1 year total shareholder return trails its solid 3 and...

AbbVie (ABBV) has packed several catalysts into a few weeks, including fresh blood cancer data heading to ASH 2025, an FDA green light for EPKINLY in follicular lymphoma, and a dividend hike. See our latest analysis for AbbVie. Those oncology and neuroscience wins are landing against a strong tape, with AbbVie’s latest share price at $230.24 and a roughly 28 percent year to date share price return, while its five year total shareholder return of about 157 percent signals durable momentum...

Whether you are wondering if Daiichi Sankyo Company is starting to look like good value after a rough stretch, or if the market still sees more downside ahead, this breakdown will help you sort signal from noise. The stock is down 7.8% over the last week, 2.9% over the last month, and a steep 26.2% over the past year, even though long term holders over 5 years are still sitting on a 10.7% gain. Recent headlines have focused on Daiichi Sankyo's expanding oncology portfolio and major global...

Oppenheimer recently initiated coverage on Theravance Biopharma with an Outperform rating, emphasizing the importance of the Phase 3 ampreloxetine readout expected in the first quarter of 2026 and the company’s virtual key opinion leader event on this program. The focus on ampreloxetine as a potential billion-dollar therapy in a rare neurogenic condition highlights how pivotal this single late-stage asset has become for Theravance’s future prospects and risk profile. We’ll now explore how...

If you have been wondering whether AtkinsRéalis Group is still good value after its huge run up, you are not alone. This stock has become a favorite talking point for investors trying to separate momentum from true underlying worth. Even after pulling back around 11.4% over the last month and slipping 0.4% in the past week, the share price is still up 16.0% year to date, 13.2% over the last year and an impressive 254.5% over three years and 279.4% over five years. This naturally raises the...

If you are wondering whether Novavax at around $6.84 is a beaten down bargain or a value trap, you are not alone. That is exactly what this breakdown is going to tackle. The stock has slipped recently, with returns of about -1.6% over the last week, -13.5% over the last month and -20.2% year to date, on top of a rough -94.1% over five years. Those moves reflect shifting sentiment around Novavax's vaccine pipeline and its ability to carve out a sustainable niche in a post pandemic market...

In recent days, S&P Global completed a US$1.00 billion private placement of senior unsecured notes due 2031 and 2035, while also announcing new AI data integrations with Amazon Web Services’ Amazon Quick Suite for financial, market, and energy insights. Together, the AI-focused AWS integrations and fresh debt issuance highlight how S&P Global is pairing data innovation with additional financial flexibility for future initiatives. Next, we’ll examine how this combination of new AWS AI...